202 related articles for article (PubMed ID: 16936276)
1. Complement plays an important role in spinal cord injury and represents a therapeutic target for improving recovery following trauma.
Qiao F; Atkinson C; Song H; Pannu R; Singh I; Tomlinson S
Am J Pathol; 2006 Sep; 169(3):1039-47. PubMed ID: 16936276
[TBL] [Abstract][Full Text] [Related]
2. A new treatment for neurogenic inflammation caused by EV71 with CR2-targeted complement inhibitor.
Qiu S; Liu N; Jia L; Yang G; Su W; Li J; Song L; Yang C; Wang J; Zhang C; Wang Z; Qiao F; Tomlinson S; Atkinson C; Sun Y; Huang L; Song H; Wang Y; Li Z
Virol J; 2012 Nov; 9():285. PubMed ID: 23173749
[TBL] [Abstract][Full Text] [Related]
3. Complement-dependent P-selectin expression and injury following ischemic stroke.
Atkinson C; Zhu H; Qiao F; Varela JC; Yu J; Song H; Kindy MS; Tomlinson S
J Immunol; 2006 Nov; 177(10):7266-74. PubMed ID: 17082645
[TBL] [Abstract][Full Text] [Related]
4. A complement C3 inhibitor specifically targeted to sites of complement activation effectively ameliorates collagen-induced arthritis in DBA/1J mice.
Song H; Qiao F; Atkinson C; Holers VM; Tomlinson S
J Immunol; 2007 Dec; 179(11):7860-7. PubMed ID: 18025232
[TBL] [Abstract][Full Text] [Related]
5. Natural IgM antibodies that bind neoepitopes exposed as a result of spinal cord injury , drive secondary injury by activating complement.
Narang A; Qiao F; Atkinson C; Zhu H; Yang X; Kulik L; Holers VM; Tomlinson S
J Neuroinflammation; 2017 Jun; 14(1):120. PubMed ID: 28629465
[TBL] [Abstract][Full Text] [Related]
6. Targeted Complement Inhibition Protects Vascularized Composite Allografts From Acute Graft Injury and Prolongs Graft Survival When Combined With Subtherapeutic Cyclosporine A Therapy.
Zhu P; Bailey SR; Lei B; Paulos CM; Atkinson C; Tomlinson S
Transplantation; 2017 Apr; 101(4):e75-e85. PubMed ID: 28045880
[TBL] [Abstract][Full Text] [Related]
7. Targeted complement inhibition by C3d recognition ameliorates tissue injury without apparent increase in susceptibility to infection.
Atkinson C; Song H; Lu B; Qiao F; Burns TA; Holers VM; Tsokos GC; Tomlinson S
J Clin Invest; 2005 Sep; 115(9):2444-53. PubMed ID: 16127466
[TBL] [Abstract][Full Text] [Related]
8. Complement Inhibition Alleviates Cholestatic Liver Injury Through Mediating Macrophage Infiltration and Function in Mice.
Guo Z; Chen J; Zeng Y; Wang Z; Yao M; Tomlinson S; Chen B; Yuan G; He S
Front Immunol; 2021; 12():785287. PubMed ID: 35069557
[TBL] [Abstract][Full Text] [Related]
9. Deficiency of complement receptors CR2/CR1 in Cr2⁻/⁻ mice reduces the extent of secondary brain damage after closed head injury.
Neher MD; Rich MC; Keene CN; Weckbach S; Bolden AL; Losacco JT; Patane J; Flierl MA; Kulik L; Holers VM; Stahel PF
J Neuroinflammation; 2014 May; 11():95. PubMed ID: 24885042
[TBL] [Abstract][Full Text] [Related]
10. A novel targeted inhibitor of the alternative pathway of complement and its therapeutic application in ischemia/reperfusion injury.
Huang Y; Qiao F; Atkinson C; Holers VM; Tomlinson S
J Immunol; 2008 Dec; 181(11):8068-76. PubMed ID: 19017999
[TBL] [Abstract][Full Text] [Related]
11. Tissue-specific deletion of Crry from mouse proximal tubular epithelial cells increases susceptibility to renal ischemia-reperfusion injury.
Miao J; Lesher AM; Miwa T; Sato S; Gullipalli D; Song WC
Kidney Int; 2014 Oct; 86(4):726-37. PubMed ID: 24850152
[TBL] [Abstract][Full Text] [Related]
12. Low-dose targeted complement inhibition protects against renal disease and other manifestations of autoimmune disease in MRL/lpr mice.
Atkinson C; Qiao F; Song H; Gilkeson GS; Tomlinson S
J Immunol; 2008 Jan; 180(2):1231-8. PubMed ID: 18178863
[TBL] [Abstract][Full Text] [Related]
13. Modulation of post-stroke degenerative and regenerative processes and subacute protection by site-targeted inhibition of the alternative pathway of complement.
Alawieh A; Elvington A; Zhu H; Yu J; Kindy MS; Atkinson C; Tomlinson S
J Neuroinflammation; 2015 Dec; 12():247. PubMed ID: 26714866
[TBL] [Abstract][Full Text] [Related]
14. Mesangial cell complement receptor 1-related protein y limits complement-dependent neutrophil accumulation in immune complex glomerulonephritis.
Bao L; Wang Y; Chen P; Sarav M; Haas M; Minto AW; Petkova M; Quigg RJ
Immunology; 2009 Sep; 128(1 Suppl):e895-904. PubMed ID: 19740350
[TBL] [Abstract][Full Text] [Related]
15. A targeted inhibitor of the alternative complement pathway reduces angiogenesis in a mouse model of age-related macular degeneration.
Rohrer B; Long Q; Coughlin B; Wilson RB; Huang Y; Qiao F; Tang PH; Kunchithapautham K; Gilkeson GS; Tomlinson S
Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3056-64. PubMed ID: 19264882
[TBL] [Abstract][Full Text] [Related]
16. Complement is activated in kidney by endotoxin but does not cause the ensuing acute renal failure.
Cunningham PN; Holers VM; Alexander JJ; Guthridge JM; Carroll MC; Quigg RJ
Kidney Int; 2000 Oct; 58(4):1580-7. PubMed ID: 11012892
[TBL] [Abstract][Full Text] [Related]
17. Complement receptor C3aR1 controls neutrophil mobilization following spinal cord injury through physiological antagonism of CXCR2.
Brennan FH; Jogia T; Gillespie ER; Blomster LV; Li XX; Nowlan B; Williams GM; Jacobson E; Osborne GW; Meunier FA; Taylor SM; Campbell KE; MacDonald KP; Levesque JP; Woodruff TM; Ruitenberg MJ
JCI Insight; 2019 May; 4(9):. PubMed ID: 31045582
[TBL] [Abstract][Full Text] [Related]
18. The alternative and terminal pathways of complement mediate post-traumatic spinal cord inflammation and injury.
Qiao F; Atkinson C; Kindy MS; Shunmugavel A; Morgan BP; Song H; Tomlinson S
Am J Pathol; 2010 Dec; 177(6):3061-70. PubMed ID: 20952585
[TBL] [Abstract][Full Text] [Related]
19. A new therapeutic strategy for lung tissue injury induced by influenza with CR2 targeting complement inhibitor.
Zhang C; Xu Y; Jia L; Yang Y; Wang Y; Sun Y; Huang L; Qiao F; Tomlinson S; Liu X; Zhou Y; Song H
Virol J; 2010 Feb; 7():30. PubMed ID: 20144216
[TBL] [Abstract][Full Text] [Related]
20. Dissecting the complement pathway in hepatic injury and regeneration with a novel protective strategy.
Marshall KM; He S; Zhong Z; Atkinson C; Tomlinson S
J Exp Med; 2014 Aug; 211(9):1793-805. PubMed ID: 25113972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
